Novartis proposes dividend raise to CHF 3.70
2026-02-04 01:24:20 ET
More on Novartis
- Novartis: Upside Increasingly Capped, 2026 Will Be A Transition Year (Rating Downgrade)
- Novartis AG (NVS) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Novartis AG (NVS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Novartis reports mixed Q4 results; initates FY26 soft outlook
- Novartis Q4 2025 Earnings Preview
Read the full article on Seeking Alpha
For further details see:
Novartis proposes dividend raise to CHF 3.70NASDAQ: NVS
NVS Trading
-0.32% G/L:
$154.04 Last:
978,559 Volume:
$154.69 Open:



